Author, study [reference] | Patients (n) and operations | LVEF cutoffs | Administration timing and dosages |
---|---|---|---|
Low LVEF only | |||
 Erb et al., 2014 [19] | 33 On-pump CABG (with or without valve) | <30% | Before incision 12.5-mg total dose at 0.1 μg∙kg−1∙minute−1 |
 Levin et al., 2012 [20] | 252 On-pump CABG only | <25% | Preoperative 10-μg/kg bolus; 0.1 μg∙kg−1∙minute−1 for 23 h |
 Mehta et al., 2017 [13] | 849 On-pump cardiac surgery | <35% | Before incision 0.2 μg/kg/minute for 1 h; 0.1 μg∙kg−1∙minute−1 for 23 h |
 Shah et al., 2014 [21] | 50 Off-pump CABG only | <30% | Preoperative 0.133 μg∙kg−1∙minute−1 for 24 h |
 Sharma et al., 2014 [22] | 40 CABG and mitral valve repair | <30% | Preoperative 200 μg∙kg−1 for 24 h |
 Lomivorotov et al., 2012a [17] | 60 On-pump CABG only | <35% | Before incision 12-μg∙kg−1 bolus; 0.1 μg∙kg−1∙minute−1 for 24 h |
LCOS only | |||
– | – | – | – |
Low LVEF and LCOS | Â | Â | Â |
 Landoni et al., 2017 [14] | 504 All cardiac surgery | <25%/or LCOSb | Mainly postoperativeb 0.05 μg∙kg−1∙minute−1 for 48 h or until ICU discharge |